Maurizio Zangari

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 13

Top Venues

American journal of hematology

British journal of haematology

BioMed research international

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

This page only lists publications with an associated author ORCID identifier.

Publications

Samer Al Hadidi, Obada E Ababneh, Carolina D Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Guido Tricot, John Shaughnessy, Fenghuang Zhan, Jeffrey Sawyer, Eric Robb Siegel, Maurizio Zangari, Bart Barlogie, Frits Van Rhee
Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma. American journal of hematology (2024)
Othman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, Mark Forsberg, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Tanvi Patel, Asis Shrestha, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Mansi R Shah, Aishee Bag, Anita D Souza, Carolina Schinke, Rajshekhar Chakraborty, Nishi Shah, Meera Mohan
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies. British journal of haematology (2024)
Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal, Sharmilan Thanendrarajan, Sabarinath Venniyil Radhakrishnan, Samer Al Hadidi, Carlyn Rose Tan, Sham Mailankody, Malin Hultcrantz, Neha Korde, Hani Hassoun, Alexander M Lesokhin, Sheeba K Thomas, Krina K Patel, Elisabet E Manasanch, Donna M Weber, Aniko Szabo, Gregory P Kaufman, Hans C Lee, Maurizio Zangari, Frits Van Rhee, Saad Z Usmani, Anita D Souza, Robert Z Orlowski, Carolina D Schinke
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience. American journal of hematology 97 (7) (2022)
Meera Mohan, Sravani Gundarlapalli, Aniko Szabo, Naveen Yarlagadda, Sunilkumar Kakadia, Manojna Konda, Anusha Jillella, Amisha Fnu, Yetunde Ogunsesan, Lakshmi Yarlagadda, Nishant Thalambedu, Hussain Munawar, Monica Graziutti, Samer Al Hadidi, Daisy Alapat, Sharmilan Thanendrarajan, Maurizio Zangari, Frits Van Rhee, Carolina D Schinke
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma. American journal of hematology 97 (6) (2022)
Hassan Mohammed Abushukair, Sebawe Syaj, Obada E Ababneh, Aref Qarqash, Carolina D Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits Van Rhee, Samer Al Hadidi
First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta-analysis. American journal of hematology 97 (7) (2022)
Meera Mohan, Lisa E Rein, Nishanth Thalambedu, Yetunde Ogunsesan, Munawwar Hussain, Jaskirat Sethi, Fatima Khan, Sravani Gundarlapalli, Lakshmi Yarlagadda, Binod Dhakal, Mary Price, Megan Shirey, Davie Warner, Sharmilan Thanendrarajan, Siegfried Janz, Sabarinath Venniyil Radhakrishnan, Samer Al Hadidi, Aniko Szabo, Anita D Souza, Maurizio Zangari, Frits Van Rhee, Saurabh Chhabra, Carolina D Schinke
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience. American journal of hematology 97 (12) (2022)
Meera Mohan, Aniko Szabo, Naveen Yarlagadda, Sravani Gundarlapalli, Sharmilan Thanendrarajan, Samantha Kendrick, Carolina D Schinke, Daisy Alapat, Jeffrey Sawyer, Erming Tian, Guido Tricot, Frits Van Rhee, Maurizio Zangari
Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma. American journal of hematology 96 (9) (2021)
Eileen Mary Boyle, Adam Rosenthal, Yan Wang, Philip Farmer, Michael Rutherford, Cody Ashby, Michael Bauer, Sarah K Johnson, Christopher P Wardell, Antje Hoering, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Bart Barlogie, Faith E Davies, Brian A Walker, Frits van Rhee, Gareth J Morgan
High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse. British journal of haematology 195 (2) (2021)
Meera Mohan, Niels Weinhold, Carolina Schinke, Sharmilan Thanedrarajan, Leo Rasche, Jeffrey R Sawyer, Erming Tian, Frits van Rhee, Maurizio Zangari
Daratumumab in high-risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome. British journal of haematology 189 (1) (2019)
Gerhard C Hildebrandt, Tamara Berno, Andrea Gurule, Meera Mohan, Doonghoon Yoon, Mohamed Salama, Maurizio Zangari
Effect of low-dose bortezomib on bone formation in smouldering multiple myeloma. British journal of haematology 184 (2) (2018)
Syed J Mehdi, Sarah K Johnson, Joshua Epstein, Maurizio Zangari, Pingping Qu, Antje Hoering, Frits van Rhee, Carolina Schinke, Sharmilan Thanendrarajan, Bart Barlogie, Faith E Davies, Gareth J Morgan, Shmuel Yaccoby
Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes. British journal of haematology 184 (4) (2018)
Meera Mohan, Amy Buros, Pankaj Mathur, Neriman Gokden, Manisha Singh, Sandra P Susanibar-Adaniya, Jorge Jo Kamimoto, Shadiqul Hoque, Muthukumar Radhakrishnan, Aasiya Matin, Cynthia Davis, Monica Grazziutti, Sharmilan Thanendrarajan, Frits van Rhee, Maurizio Zangari, Faith Davies, Gareth Morgan, Joshua Epstein, Bart Barlogie, Carolina D Schinke
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease. American journal of hematology 92 (8) (2017)
Meera Mohan, Rohan S Samant, Donghoon Yoon, Amy F Buros, Antonio Branca, Corey O Montgomery, Richard Nicholas, Larry J Suva, Roy Morello, Sharmilan Thanendrarajan, Carolina Schinke, Shmuel Yaccoby, Frits van Rhee, Faith E Davies, Gareth J Morgan, Maurizio Zangari
Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 32 (6) (2017)
Fenghuang Zhan, Maurizio Zangari, Lugui Qiu
Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeutics. BioMed research international 2015 (2015)

Maurizio Zangari.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maurizio Zangari